6. Other Conditions
Long COVID & Alzheimer's Disease
Long COVID
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition in which people continue to experience symptoms for weeks or months after the initial COVID-19 infection has resolved. The symptoms can include fatigue, shortness of breath, chest pain, joint pain, difficulty sleeping, memory and concentration problems, and depression or anxiety. It is not yet fully understood why some people develop long COVID, but it is believed to be related to the body's immune response to the virus, rather than the virus itself. Long COVID can affect people of all ages, including those who had mild or asymptomatic COVID-19 infections.
Benefits of IV Infusions
This safe anaesthetic drug, in infusions, has been found to significantly reduce fatigue scores compared to placebo in a double-blind, placebo-controlled, crossover study in bipolar disorder. Recent research suggests that this infusion may have anti-inflammatory effects in some depressed patients, but further studies are needed to understand the clinical relevance of these changes. In addition, COVID-19 can affect the brain and cause neuropsychiatric symptoms such as cognitive deficits, anxiety, depression, and seizures. Researchers are exploring interventions to reduce these symptoms, including the use of infusion therapy as an n-Methyl d-Aspartate (NMDA) receptor antagonist.
Alzheimer's Disease
Alzheimer's disease is a progressive and irreversible neurological disorder that affects brain function, particularly memory, thinking, and behavior. It is the most common form of dementia, accounting for 60-80% of all dementia cases. Alzheimer's disease is caused by the accumulation of abnormal proteins in the brain, including beta-amyloid and tau. These proteins cause the death of brain cells and the gradual decline of cognitive function. Alzheimer's disease usually progresses slowly, with early symptoms including difficulty remembering recent events, disorientation, and problems with language. As the disease advances, individuals may experience personality and behavioral changes, difficulty with self-care, and eventually lose the ability to communicate. There is currently no cure for Alzheimer's disease, but medications and supportive therapies can help manage symptoms and improve quality of life for those affected.
Benefits of IV Infusions
Infusion therapy has been suggested as a potential treatment for Alzheimer's disease, based on its similar pharmacologic profile to memantine, one of the most commonly prescribed drugs for Alzheimer's patients. Existing literature provides a strong scientific rationale for testing the precognitive effects of this infusion in Alzheimer's patients.
.
.
.
.